Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Abraham Morgentaler & Monica Caliber. (2019) Safety of testosterone therapy in men with prostate cancer. Expert Opinion on Drug Safety 18:11, pages 1065-1076.
Read now
Read now
Alekhya Mascarenhas, Sobia Khan, Radha Sayal, Sandra Knowles, Tara Gomes & Julia E. Moore. (2016) Factors that may be influencing the rise in prescription testosterone replacement therapy in adult men: a qualitative study. The Aging Male 19:2, pages 90-95.
Read now
Read now
Louis Gooren. (2016) Diagnosing hypogonadism and treating decisions in different parts of the world: shifts in patterns between 2006 and 2015. The Aging Male 19:1, pages 46-53.
Read now
Read now
Articles from other publishers (22)
Konstantinos Dimitropoulos, Paolo Verze, Thomas Van den Broeck, Andrea Salonia, Cathy Yuhong Yuan, Konstantinos Hatzimouratidis & Gert Dohle. (2019) What are the benefits and harms of testosterone therapy for male sexual dysfunction?—a systematic review. International Journal of Impotence Research 31:6, pages 380-391.
Crossref
Crossref
Alex A. Straftis & Peter B. Gray. (2019) Sex, Energy, Well-Being and Low Testosterone: An Exploratory Survey of U.S. Men’s Experiences on Prescription Testosterone. International Journal of Environmental Research and Public Health 16:18, pages 3261.
Crossref
Crossref
Jethro C.C. Kwong, Yonah Krakowsky & Ethan Grober. (2019) Testosterone Deficiency: A Review and Comparison of Current Guidelines. The Journal of Sexual Medicine 16:6, pages 812-820.
Crossref
Crossref
Abdulmaged M. Traish & Abraham Morgentaler. 2019. Sex Differences in Cardiovascular Physiology and Pathophysiology. Sex Differences in Cardiovascular Physiology and Pathophysiology
321
354
.
Michael A. Bell, Jeffrey D. Campbell, Gregory Joice, Nikolai A. Sopko & Arthur L. Burnett. (2018) Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer. The World Journal of Men's Health 36:2, pages 103.
Crossref
Crossref
Abdulmaged M. Traish. (2018) Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency. Sexual Medicine Reviews 6:1, pages 86-105.
Crossref
Crossref
Ruben Wesselius, Mirjam Schotman, Martje Schotman & Alberto M Pereira. (2017) A Patient (46XX) With Congenital Adrenal Hyperplasia and Prostate Cancer: A Case Report. Journal of the Endocrine Society 1:9, pages 1213-1216.
Crossref
Crossref
Kristi L. Lawrence, Felicia Stewart & Brandi M. Larson. (2017) Approaches to male hypogonadism in primary care. The Nurse Practitioner 42:2, pages 32-37.
Crossref
Crossref
Mohit Khera, Ganesh Adaikan, Jacques Buvat, Serge Carrier, Amr El-Meliegy, Kostas Hatzimouratidis, Andrew McCullough, Abraham Morgentaler, Luiz Otavio Torres & Andrea Salonia. (2016) Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). The Journal of Sexual Medicine 13:12, pages 1787-1804.
Crossref
Crossref
Alan L. Kaplan, Jim C. Hu, Abraham Morgentaler, John P. Mulhall, Claude C. Schulman & Francesco Montorsi. (2016) Testosterone Therapy in Men With Prostate Cancer. European Urology 69:5, pages 894-903.
Crossref
Crossref
Abraham Morgentaler. (2016) Controversies and Advances With Testosterone Therapy: A 40-Year Perspective. Urology 89, pages 27-32.
Crossref
Crossref
Christina Dimopoulou, Iuliana Ceausu, Herman Depypere, Irene Lambrinoudaki, Alfred Mueck, Faustino R. Pérez-López, Margaret Rees, Yvonne T. van der Schouw, Levent M. Senturk, Tommaso Simonsini, John C. Stevenson, Petra Stute & Dimitrios G. Goulis. (2016) EMAS position statement: Testosterone replacement therapy in the aging male. Maturitas 84, pages 94-99.
Crossref
Crossref
Ahmad Haider, Michael Zitzmann, Gheorghe Doros, Hendrik Isbarn, Peter Hammerer & Aksam Yassin. (2015) Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy: Observations from 5-Year Median Followup of 3 Registries. Journal of Urology 193:1, pages 80-86.
Crossref
Crossref
Eberhard Nieschlag. (2015) Current topics in testosterone replacement of hypogonadal men. Best Practice & Research Clinical Endocrinology & Metabolism 29:1, pages 77-90.
Crossref
Crossref
Abraham Morgentaler, Janet A. Benesh, Bela S. Denes, Natalia Kan‐Dobrosky, Diala Harb & Michael G. Miller. (2014) Factors Influencing Prostate‐Specific Antigen Response among Men Treated with Testosterone Therapy for 6 Months. The Journal of Sexual Medicine 11:11, pages 2818-2825.
Crossref
Crossref
Bruce R. Kava. (2014) To Treat or Not to Treat with Testosterone Replacement Therapy: a Contemporary Review of Management of Late-Onset Hypogonadism and Critical Issues Related to Prostate Cancer. Current Urology Reports 15:7.
Crossref
Crossref
Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia & Abraham Morgentaler. (2014) A New Era of Testosterone and Prostate Cancer: From Physiology to Clinical Implications. European Urology 65:1, pages 115-123.
Crossref
Crossref
Alan L. Kaplan & Jim C. Hu. (2013) Use of Testosterone Replacement Therapy in the United States and Its Effect on Subsequent Prostate Cancer Outcomes. Urology 82:2, pages 321-326.
Crossref
Crossref
Tomas L. Griebling. (2013) Late Onset Hypogonadism, Testosterone Replacement Therapy, and Sexual Health in Elderly Men. Current Translational Geriatrics and Experimental Gerontology Reports 2:2, pages 76-83.
Crossref
Crossref
Peter T. K. Chan. 2013. Biennial Review of Infertility. Biennial Review of Infertility
31
48
.
J. J. Carrero & P. Stenvinkel. (2012) The vulnerable man: impact of testosterone deficiency on the uraemic phenotype. Nephrology Dialysis Transplantation 27:11, pages 4030-4041.
Crossref
Crossref
Mark R. Feneley & Malcolm Carruthers. (2012) Is Testosterone Treatment Good for the Prostate? Study of Safety during Long‐Term Treatment. The Journal of Sexual Medicine 9:8, pages 2138-2149.
Crossref
Crossref